- Repurposing Drugs in Small Animal Oncology
Antonio Giuliano et al, 2022, Animals CrossRef - In vitro antioxidant and anticancer activities of Smilax corbularia extract combined with Phellinus linteus extract against breast cancer cell lines
Alvi Syukriya et al, 2023, Biomedical Reports CrossRef - In Vitro Drug Repurposing: Focus on Vasodilators
Eduarda Ribeiro et al, 2023, Cells CrossRef - Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches
Ivan Lučić et al, 2023, International Journal of Molecular Sciences CrossRef - Dihydropyrimidinones: Recent Synthetic and Pharmacological Perspectives with Special Focus on Colon Cancer
, 2023, Journal of Pharmaceutical Research and Development CrossRef - Amlodipine inhibits Synaptotagmin-4’s oncogenic activity on gastric cancer proliferation by targeting calcium signaling
Wen Huang et al, 2024, Functional & Integrative Genomics CrossRef - Amlodipine protects against methotrexate nephrotoxicity by modulating inflammation, oxidative stress, and apoptosis through NF-κB/PPAR-β/caspase 3 pathways
Shahid Karim et al, 2024, Journal of Advanced Pharmacy Education and Research CrossRef - Amlodipine inhibits the proliferation and migration of esophageal carcinoma cells through the induction of endoplasmic reticulum stress
Yan-Min Chen et al, 2024, World Journal of Gastroenterology CrossRef - Unmasking the complex roles of hypocalcemia in cancer, COVID-19, and sepsis: Engineered nanodelivery and diagnosis
Elham Ghafouri et al, 2023, Environmental Research CrossRef - NFAT activation by FKBP52 promotes cancer cell proliferation by suppressing p53
Shunsuke Hanaki et al, 2024, Life Science Alliance CrossRef - The interactive effect of amlodipine and chemotherapeutic agents in lung cancer cells
Mohammad A.Y. Alqudah et al, 2022, Informatics in Medicine Unlocked CrossRef - Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas
Graziella R. de Sousa et al, 2023, Cancer Gene Therapy CrossRef